• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低氧血症而非高氧血症预示着重度慢性阻塞性肺疾病急性加重期的预后更差——一项观察性研究。

Hypoxemia and not hyperoxemia predicts worse outcome in severe COPD exacerbations - an observational study.

作者信息

Sandau Charlotte, Hansen Ejvind Frausing, Pedersen Lars, Jensen Jens Ulrik Stæhr

机构信息

Department of Respiratory Medicine and Endocrinology, Pulmonary Section, Copenhagen University Hospital Hvidovre, Copenhagen, Denmark.

Department of Respiratory Medicine and Infectious Diseases, Copenhagen Univervisity Hospital Bispebjerg Hospital, Copenhagen, Denmark.

出版信息

Eur Clin Respir J. 2022 Dec 5;10(1):2153644. doi: 10.1080/20018525.2022.2153644. eCollection 2023.

DOI:10.1080/20018525.2022.2153644
PMID:36505897
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9731582/
Abstract

OBJECTIVES

For patients admitted with an acute exacerbation of COPD (AECOPD) and a need for supplementary oxygen therapy, to determine if peripheral oxygen saturation < 88% (hypoxemia) or >92% (hyperoxemia), within first 24 hours of admission, is associated with 'treatment failure' or fewer days alive and out of hospital within 14 days after admission.

DESIGN

A retrospective multicenter observational study, reviewing consecutive data on SpO2, oxygen, and drug administration at three predefined time points, on adverse events in patients admitted with COPD between December 2019 and June 2020. Multivariable logistic regression analysis, Mann Whitney U- and Chi-square-test were used.

SETTING

Acute hospital setting, across four different hospitals in the capital region of Denmark.

PARTICIPANTS

Patients with a confirmed diagnosis of COPD admitted with an acute exacerbation and an oxygen need within the first 24 hours admission.

RESULTS

In total 289 COPD patients were included. The median age was 74.8 years [interquartile range (IQR):69.6 to 81.8], 191 were female and 132 patients experienced 'treatment failure'. A minimum of one episode of hypoxemia (SpO < 88%) within first 24 hours was associated with having a low number (≤4) of days alive and out of hospital within 14 days after admission: OR 2.4 (95%CI 1.2 to 4.8), p = 0.02, absolute risk 44% vs. 26% p = 0.01, Chi-square. Comparable results were observed after 30 days of follow-up: OR 2.6 (95% CI 1.0 to7.1), p = 0.05. A minimum of one measurement of hyperoxemia (SpO > 92%), within first 24 hours of admission was not associated with low number of days alive and out of hospital within 14 days OR 1.0 (95% CI 0.5 to 2.1) nor at 30 days.

CONCLUSION

For admitted patients with AECOPD, being hypoxemic ever within the first 24 hours after admission is associated with a substantially increased risk of a poor prognosis.

摘要

目的

对于因慢性阻塞性肺疾病急性加重(AECOPD)入院且需要补充氧气治疗的患者,确定入院后24小时内外周血氧饱和度<88%(低氧血症)或>92%(高氧血症)是否与“治疗失败”或入院后14天内存活且出院天数减少有关。

设计

一项回顾性多中心观察性研究,回顾了2019年12月至2020年6月期间因慢性阻塞性肺疾病入院患者在三个预定义时间点的连续血氧饱和度、氧气和药物给药数据以及不良事件。采用多变量逻辑回归分析、曼-惠特尼U检验和卡方检验。

设置

丹麦首都地区四家不同医院的急性医院环境。

参与者

确诊为慢性阻塞性肺疾病且在入院后24小时内因急性加重需要吸氧的患者。

结果

共纳入289例慢性阻塞性肺疾病患者。中位年龄为74.8岁[四分位间距(IQR):69.6至81.8],191例为女性,132例患者出现“治疗失败”。入院后24小时内至少有一次低氧血症发作(SpO<88%)与入院后14天内存活且出院天数少(≤4天)相关:比值比2.4(95%置信区间1.2至4.8),p = 0.02,绝对风险44%对26%,p = 0.01,卡方检验。随访30天后观察到类似结果:比值比2.6(95%置信区间1.0至7.1),p = 0.05。入院后24小时内至少有一次高氧血症测量值(SpO>92%)与14天内或30天内存活且出院天数少无关,比值比1.0(95%置信区间0.5至2.1)。

结论

对于因AECOPD入院的患者,入院后24小时内出现低氧血症与预后不良风险大幅增加相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3715/9731582/6f1d8451eaf4/ZECR_A_2153644_F0002_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3715/9731582/1448dfa89c58/ZECR_A_2153644_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3715/9731582/6f1d8451eaf4/ZECR_A_2153644_F0002_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3715/9731582/1448dfa89c58/ZECR_A_2153644_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3715/9731582/6f1d8451eaf4/ZECR_A_2153644_F0002_B.jpg

相似文献

1
Hypoxemia and not hyperoxemia predicts worse outcome in severe COPD exacerbations - an observational study.低氧血症而非高氧血症预示着重度慢性阻塞性肺疾病急性加重期的预后更差——一项观察性研究。
Eur Clin Respir J. 2022 Dec 5;10(1):2153644. doi: 10.1080/20018525.2022.2153644. eCollection 2023.
2
Eosinophil-guided corticosteroid therapy in patients admitted to hospital with COPD exacerbation (CORTICO-COP): a multicentre, randomised, controlled, open-label, non-inferiority trial.嗜酸粒细胞指导下的 COPD 加重住院患者的皮质类固醇治疗(CORTICO-COP):一项多中心、随机、对照、开放标签、非劣效性试验。
Lancet Respir Med. 2019 Aug;7(8):699-709. doi: 10.1016/S2213-2600(19)30176-6. Epub 2019 May 20.
3
Hyperoxemia after reperfusion in cardiac arrest patients: a potential dose-response association with 30-day survival.心脏停搏患者再灌注后高氧血症:与 30 天生存率的潜在剂量反应关系。
Crit Care. 2023 Mar 6;27(1):86. doi: 10.1186/s13054-023-04379-9.
4
Automated Oxygen Administration Alleviates Dyspnea in Patients Admitted with Acute Exacerbation of COPD: A Randomized Controlled Trial.自动化给氧治疗缓解 COPD 急性加重患者呼吸困难的随机对照试验。
Int J Chron Obstruct Pulmon Dis. 2023 Apr 18;18:599-614. doi: 10.2147/COPD.S397782. eCollection 2023.
5
The Impact of Hyperoxia on Outcome of Patients Treated with Noninvasive Respiratory Support.高氧对无创呼吸支持治疗患者结局的影响。
Can Respir J. 2020 May 6;2020:3953280. doi: 10.1155/2020/3953280. eCollection 2020.
6
Neutrophil-to-Lymphocyte Ratio Predicts Clinical Outcome of Severe Acute Exacerbation of COPD in Frequent Exacerbators.中性粒细胞与淋巴细胞比值预测频繁加重 COPD 急性加重期患者的临床转归。
Int J Chron Obstruct Pulmon Dis. 2021 Feb 17;16:341-349. doi: 10.2147/COPD.S290422. eCollection 2021.
7
Effect of different corticosteroid regimes for hospitalised patients with exacerbated COPD: pooled analysis of individual participant data from the REDUCE and CORTICO-COP trials.不同糖皮质激素治疗方案对加重期 COPD 住院患者的影响:REDCUE 和 CORTICO-COP 试验个体参与者数据的汇总分析。
Respir Res. 2021 May 21;22(1):155. doi: 10.1186/s12931-021-01745-5.
8
Hypoxemic and hyperoxemic likelihood in pulse oximetry ranges: NICU observational study.脉搏血氧饱和度范围内低氧血症和高氧血症的可能性:NICU 观察性研究。
Arch Dis Child Fetal Neonatal Ed. 2019 May;104(3):F274-F279. doi: 10.1136/archdischild-2017-314448. Epub 2018 Jun 20.
9
Admission oxygen saturation and all-cause in-hospital mortality in acute myocardial infarction patients: data from the MIMIC-III database.急性心肌梗死患者的入院血氧饱和度与全因院内死亡率:来自MIMIC-III数据库的数据
Ann Transl Med. 2020 Nov;8(21):1371. doi: 10.21037/atm-20-2614.
10
Soluble urokinase plasminogen activator receptor predicts mortality in exacerbated COPD.可溶性尿激酶型纤溶酶原激活物受体可预测 COPD 恶化患者的死亡率。
Respir Res. 2018 May 21;19(1):97. doi: 10.1186/s12931-018-0803-2.

引用本文的文献

1
Prediction of 12-month exacerbation-related readmission in hospitalized patients with COPD: a single-center study in China.慢性阻塞性肺疾病住院患者12个月内与急性加重相关再入院的预测:一项中国单中心研究
Eur J Med Res. 2025 Aug 20;30(1):773. doi: 10.1186/s40001-025-03042-z.
2
Assessment of Initial Oxygenation Levels of Chronic Obstructive Pulmonary Disease (COPD) and Their Impact on Basis and Vital Tools: Retrospective Cohort Study From India.慢性阻塞性肺疾病(COPD)初始氧合水平评估及其对基础和重要工具的影响:来自印度的回顾性队列研究
Cureus. 2024 Dec 10;16(12):e75470. doi: 10.7759/cureus.75470. eCollection 2024 Dec.
3
Oxygen Therapy in COPD.

本文引用的文献

1
Delirium prevalence in geriatric emergency department patients: A systematic review and meta-analysis.老年急诊患者谵妄患病率的系统评价和荟萃分析。
Am J Emerg Med. 2022 Sep;59:121-128. doi: 10.1016/j.ajem.2022.05.058. Epub 2022 Jul 1.
2
Association of dyspnoea, mortality and resource use in hospitalised patients.呼吸困难与住院患者死亡率及资源利用的相关性。
Eur Respir J. 2021 Sep 2;58(3). doi: 10.1183/13993003.02107-2019. Print 2021 Sep.
3
Oxygen therapy and inpatient mortality in COPD exacerbation.氧疗与 COPD 加重期患者的住院病死率
慢性阻塞性肺疾病的氧疗。
Respir Care. 2023 Jul;68(7):998-1012. doi: 10.4187/respcare.10876.
4
COPD Exacerbation: Why It Is Important to Avoid ICU Admission.慢性阻塞性肺疾病急性加重:为何避免入住重症监护病房很重要。
J Clin Med. 2023 May 9;12(10):3369. doi: 10.3390/jcm12103369.
Emerg Med J. 2021 Mar;38(3):170-177. doi: 10.1136/emermed-2019-209257. Epub 2020 Nov 26.
4
Proactive prophylaxis with azithromycin and hydroxychloroquine in hospitalized patients with COVID-19 (ProPAC-COVID): a statistical analysis plan.COVID-19 住院患者中阿奇霉素和羟氯喹的主动预防(ProPAC-COVID):统计分析计划。
Trials. 2020 Oct 20;21(1):867. doi: 10.1186/s13063-020-04795-0.
5
Combining opioids and benzodiazepines: effects on mortality and severe adverse respiratory events.联合使用阿片类药物和苯二氮䓬类药物:对死亡率和严重不良呼吸事件的影响。
Ann Palliat Med. 2020 Mar;9(2):542-557. doi: 10.21037/apm.2019.12.09. Epub 2020 Feb 6.
6
Time to NIV and mortality in AECOPD hospital admissions: an observational study into real world insights from National COPD Audits.NIV 应用时机与 AECOPD 住院患者死亡率:来自全国 COPD 审计的真实世界观察性研究
BMJ Open Respir Res. 2019 Aug 5;6(1):e000444. doi: 10.1136/bmjresp-2019-000444. eCollection 2019.
7
Eosinophil-guided corticosteroid therapy in patients admitted to hospital with COPD exacerbation (CORTICO-COP): a multicentre, randomised, controlled, open-label, non-inferiority trial.嗜酸粒细胞指导下的 COPD 加重住院患者的皮质类固醇治疗(CORTICO-COP):一项多中心、随机、对照、开放标签、非劣效性试验。
Lancet Respir Med. 2019 Aug;7(8):699-709. doi: 10.1016/S2213-2600(19)30176-6. Epub 2019 May 20.
8
Late presentation of acute hypercapnic respiratory failure carries a high mortality risk in COPD patients treated with ward-based NIV.在 COPD 患者中,以常规病房为基础的无创通气治疗时,急性高碳酸血症性呼吸衰竭的晚期表现与高死亡率风险相关。
Respir Med. 2019 May;151:128-132. doi: 10.1016/j.rmed.2019.04.013. Epub 2019 Apr 14.
9
Mortality and morbidity in acutely ill adults treated with liberal versus conservative oxygen therapy (IOTA): a systematic review and meta-analysis.急性危重病患者接受宽松与保守氧疗的死亡率和发病率(IOTA):系统评价和荟萃分析。
Lancet. 2018 Apr 28;391(10131):1693-1705. doi: 10.1016/S0140-6736(18)30479-3. Epub 2018 Apr 26.
10
A two centre observational study of simultaneous pulse oximetry and arterial oxygen saturation recordings in intensive care unit patients.一项针对重症监护病房患者同时进行脉搏血氧饱和度和动脉血氧饱和度记录的双中心观察性研究。
Anaesth Intensive Care. 2018 May;46(3):297-303. doi: 10.1177/0310057X1804600307.